/Companies

Kuano

13 employees on LinkedIn · 4 known investors

Find your way into Kuano

Sign up to see every warm intro you have to Kuano

  • Paths you didn't know you had: your email and LinkedIn already hold routes to the Kuano team. We find them for you
  • 2nd- and 3rd-degree connections: the friend-of-a-friend routes that take hours to manually find through your inbox or LinkedIn
  • Answers now, not in days: momentum is everything in a raise. Skip asking around whether someone knows someone

Days of research, done the moment you sign in, with every route ranked by how warm it is.

Quantum Lens develops a quantum computing and AI platform for drug discovery that simulates molecular behavior at the atomic level to guide the design of novel drug candidates. The platform targets pharmaceutical companies and biotech researchers working on small-molecule drug discovery, particularly for challenging targets like covalent inhibitors, hard-to-drug enzymes, and allosteric binding sites.

Investors · 4

Frequently asked questions

What does Kuano do?
Quantum Lens develops a quantum computing and AI platform for drug discovery that simulates molecular behavior at the atomic level to guide the design of novel drug candidates. The platform targets pharmaceutical companies and biotech researchers working on small-molecule drug discovery, particularly for challenging targets like covalent inhibitors, hard-to-drug enzymes, and allosteric binding sites.
Who are Kuano's investors?
Kuano's investors include AI Seed, Ascension, Beresford Ventures, Cambridge Angels group.